KE3034A - Pelletised medicament formulations - Google Patents

Pelletised medicament formulations

Info

Publication number
KE3034A
KE3034A KE3034A KE303480A KE3034A KE 3034 A KE3034 A KE 3034A KE 3034 A KE3034 A KE 3034A KE 303480 A KE303480 A KE 303480A KE 3034 A KE3034 A KE 3034A
Authority
KE
Kenya
Prior art keywords
pelletised
medicament formulations
medicament
formulations
pelletised medicament
Prior art date
Application number
KE3034A
Inventor
J H Bell
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10376566&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KE3034(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of KE3034A publication Critical patent/KE3034A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
KE3034A 1974-08-10 1980-03-10 Pelletised medicament formulations KE3034A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB35334/74A GB1520247A (en) 1974-08-10 1974-08-10 Pelletised medicament formulations

Publications (1)

Publication Number Publication Date
KE3034A true KE3034A (en) 1980-03-28

Family

ID=10376566

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3034A KE3034A (en) 1974-08-10 1980-03-10 Pelletised medicament formulations

Country Status (21)

Country Link
JP (1) JPS5910326B2 (en)
AR (1) AR210997A1 (en)
BE (1) BE832097A (en)
BR (1) BR7505055A (en)
CA (1) CA1072569A (en)
CY (1) CY1049A (en)
DK (1) DK145654C (en)
FI (1) FI65547C (en)
FR (1) FR2282259A1 (en)
GB (1) GB1520247A (en)
HK (1) HK17780A (en)
HU (1) HU175594B (en)
IE (1) IE41586B1 (en)
IL (1) IL47829A (en)
KE (1) KE3034A (en)
LU (1) LU73182A1 (en)
MY (1) MY8100034A (en)
NL (1) NL177980C (en)
NO (1) NO146660C (en)
SE (1) SE440595B (en)
ZA (1) ZA754765B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2741202A1 (en) * 1976-09-23 1978-03-30 Fisons Ltd SODIUM CROMOGLYCAT WITH SPECIAL BULK DENSITY
JPS6034925B2 (en) * 1979-07-31 1985-08-12 帝人株式会社 Long-acting nasal preparation and its manufacturing method
DE3636209A1 (en) * 1986-10-24 1988-04-28 Lentia Gmbh METHOD FOR PRODUCING A BINDER-FREE TABLET-TABLE CELIPROLOL HYDROCHLORIDE GRANULATE
GB8911259D0 (en) * 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament
US5198221A (en) * 1989-05-17 1993-03-30 Fisons Plc Pharmaceutical composition
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
IS1736B (en) 1993-10-01 1999-12-30 Astra Ab Methods and devices that promote increased particle aggregation
EP0721331B1 (en) * 1993-10-01 2001-12-05 AstraZeneca AB Process i
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
US6165976A (en) 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
DE4425255A1 (en) 1994-07-16 1996-01-18 Asta Medica Ag Formulation for inhalation application
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
JPH10511090A (en) 1994-12-22 1998-10-27 アストラ・アクチエボラーグ Parathyroid hormone, PTH-containing therapeutic preparation for inhalation
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
KR100386055B1 (en) 1997-03-20 2003-06-09 쉐링 코포레이션 Preparation of powder agglomerates
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
ITMI991582A1 (en) 1999-07-16 2001-01-16 Chiesi Farma Spa DUST CONSTITUTED FROM PARTICLES HAVING THE PERFECTLY SMOOTH SURFACE FOR USE AS VEHICLES FOR THE PREPARATION OF INALA MIXTURES
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
PE20011227A1 (en) 2000-04-17 2002-01-07 Chiesi Farma Spa PHARMACEUTICAL FORMULATIONS FOR DRY POWDER INHALERS IN THE FORM OF HARD AGGLOMERATES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1812574A1 (en) * 1968-12-04 1970-06-11 Riedel De Haen Ag Process for the production of biocidal granules
GB1381872A (en) * 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation

Also Published As

Publication number Publication date
HU175594B (en) 1980-09-28
FI752232A (en) 1976-02-11
SE7508967L (en) 1976-02-11
FR2282259A1 (en) 1976-03-19
CY1049A (en) 1980-08-01
NL7509080A (en) 1976-02-12
AR210997A1 (en) 1977-10-14
DK145654B (en) 1983-01-17
LU73182A1 (en) 1976-08-13
IL47829A0 (en) 1975-10-15
SE440595B (en) 1985-08-12
GB1520247A (en) 1978-08-02
CA1072569A (en) 1980-02-26
DK360875A (en) 1976-02-11
JPS5144625A (en) 1976-04-16
ZA754765B (en) 1976-07-28
FI65547C (en) 1984-06-11
MY8100034A (en) 1981-12-31
AU8385975A (en) 1977-02-24
JPS5910326B2 (en) 1984-03-08
NO146660B (en) 1982-08-09
NL177980C (en) 1986-01-02
NO752786L (en) 1976-02-11
IE41586B1 (en) 1980-02-13
NO146660C (en) 1982-11-17
DK145654C (en) 1983-08-15
NL177980B (en) 1985-08-01
FR2282259B1 (en) 1978-11-03
HK17780A (en) 1980-04-11
FI65547B (en) 1984-02-29
IL47829A (en) 1978-01-31
IE41586L (en) 1976-02-10
BE832097A (en) 1976-02-04
BR7505055A (en) 1976-08-03

Similar Documents

Publication Publication Date Title
MY8100034A (en) Pelletised medicament formulations
KE3052A (en) Pharmaceutical compositions
PH15499A (en) Inhaler
ZA74385B (en) Pharmaceutical compositions
ZA751102B (en) Pharmaceutical preparations
ZA755998B (en) Pharmaceutical compositions
AU1306576A (en) Pharmaceutical formulation
MY8100372A (en) Pharmaceutical compositions
NZ179502A (en) Ii-desoxy-omega-tetra norprostaglanding internediates pharmaceutical composition
NZ179530A (en) 9-aminoalk(en)yl-9,10-dihydro9,10-methanoanthracenes and pharmaceutical compositions
AU8487175A (en) Pharmaceutical preparations
ZA755802B (en) Pharmaceutical compositions
ZA755515B (en) Pharmaceutical formulations
PH12855A (en) Pharmaceutical compositions
HK73178A (en) Pharmaceutical compositions
AU476206B2 (en) Therapeutic composition
ZA747446B (en) Pharmaceutical preparations
IL47263A (en) 3s-methyl-7-nitro-5-phenyl-2h-1,4-benzodiazepine-2-ones, their manufacture and pharmaceutical compositions containinthem
NZ178962A (en) 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions
ZA757295B (en) Hypolipemising drug
AU494543B2 (en) Pharmaceutical formulations
ZA752061B (en) Therapeutic compositions
EG11420A (en) Inhaler
IE39585B1 (en) Pharmaceutical compostitions
CS180187B1 (en) Pharmaceutical preparation